DMIIU
Drugs Made In America Acquisition II Corp. Unit • NASDAQ
$10.16 ▲ 0.00% (+0.00)
DMIIU
Drugs Made In America Acquisition II Corp. UnitNASDAQ • $10.16 ▲ 0.00% (+0.00)
Market Cap $706.57 M
52w High $10.80
52w Low $9.94
P/E 0
Volume 1.24K
Outstanding Shares 69.54M
Market Cap $706.57 M
52w High $10.80
52w Low $9.94
P/E 0
Volume 1.24K
Outstanding Shares 69.54M
About Drugs Made In America Acquisition II Corp. Unit
https://dmaacorp.com/DMIIU is a Special Purpose Acquisition Company (SPAC), operating as a blank check firm established in the Cayman Islands. Its core objective is to identify and complete a merger or acquisition with an existing business.
CEO
Roger Bendelac
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Asset Management
Sector Financial Services
Went public September 25, 2025
Method of going public SPAC
Full time employees 2
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0